Utilizing Blood Volume Measurements in the Treatment of Heart Failure Patients
NCT ID: NCT00861770
Last Updated: 2017-05-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2008-11-30
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Restoration of Chronotropic Competence in Heart Failure Patients With Normal Ejection Fraction
NCT00670111
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
NCT07069738
Mechanically Optimizing Cardiac Preload in Heart Failure Patients
NCT04338503
Novel Vascular Biomarkers Behaviour and Clinical Value in Heart Failure and CRT
NCT02541773
Necklace-Shaped Sensor for Non-Invasive Monitoring of Stroke Volume and Cardiac Output
NCT02719301
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1 - Control
All subjects will receive blood volume measurement immediately before and 30 minutes after ultrafiltration is completed. In the control group, the treating physician will not see the blood volume measurement results and treat according to standard of care.
Ultrafiltration
Ultrafiltration based on standard of care.
2 - BVM
Ultrafiltration will be guided by blood volume measurement results.
Ultrafiltration using BVM
Ultrafiltration will be guided by blood volume measurement results.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrafiltration
Ultrafiltration based on standard of care.
Ultrafiltration using BVM
Ultrafiltration will be guided by blood volume measurement results.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \>/= 2 criteria of volume overload
1. JVD \> 7 cm
2. Ascites
3. Lower extremity edema
4. Sacral Edema
5. Pleural effusion by clinical or radiologic criteria
* CKD 3 or worse renal function ClCR \< 60 ml/min
* HCT \< 40%
* Serum Albumin \>/= 2.5 gm/dL
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Daxor Corporation
INDUSTRY
Christiana Care Health Services
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mitchell Saltzberg, MD, FACC
Role: PRINCIPAL_INVESTIGATOR
Christiana Care Health Services
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Christiana Care Health Services
Newark, Delaware, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCC28158
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.